1/166
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
Interactions of Bacteria with the Immune System
Interactions of Bacteria with the Immune System
Defense against microbes
• Innate immunity
• Adaptive immunity
• Vaccines
• Antibody therapy
• Antibiotics
Innate Immunity against Bacteria
A. To prevent bacteria from entering the body
• Physical barrier: intact skin
• Mechanical Removal: urination, mucous membrane
• Chemical microbicide: stomach acid
• Biological microbicide: lysozyme in body fluids,
• Commensal / mutual existence: microbiota in GI track
B. To destroy bacteria inside the body
• Macrophages and neutrophils: Use pattern recognition receptors (PRRs) to recognize pathogen-associated molecular patterns (PAMPs) of microbes to phagocytose and kill bacteria.
• Complement system: recognizes and forms membrane pores to lyse bacteria.
PRRs recognize _______.
PAMPs (Pathogen associated molecular patterns)
Adaptive Immunity against Bacteria
• T cells mediated adaptive immune response plays a major role in defense
against intracellular bacteria.
- CD8+ T cells
- CD4+ T cells
A: Antibody-mediated responses:
• Antigen presenting cells, CD4+ helper T cells and B cells work together to produce antibodies.
• Antibodies will
- Inactivate virulence factors
- Inactivate toxins
- Increase phagocytosis and removal
- Provide antigen-specific IgA for mucosal defense
B: Cell-mediated responses: Cytotoxic T cell-mediated lysis
Role of Inflammatory Responses
• Acute (local) inflammation
- Local vasculature response to limit injury/infection
- Neutrophil infiltration to kill bacteria
• Systemic Response:
- Acute phase protein production to tag or kill the invading bacteria (e.g. C reactive protein-CRP)
- Release of cytokines to further activate immune cells
- Stimulation of WBC production
- Fever generation to reduce bacterial activity.
- Increased serum transferrin concentration to bind iron
- Increased tissue iron storage
Pathogenic Extracellular Bacteria
(See Image)
Why is clostridium tetani considered G-???
Extracellular Bacteria and Host Immunity
• Extracellular Bacteria
- Rapid growth, if uncontrolled
- Toxins can cause local tissue damage, inflammation, septic shock in a very short time span.
• Host Immune Responses
- Innate immunity plays a major role
- At the body’s surface, various means to prevent and control bacterial growth
- Once inside the body, bacteria are quickly recognized and destroyed via multiple mechanisms.
Is extracellular bacteria associated with innate or adaptive immunity?
Innate
Intake Skin's Defense
Keratinized skin (body surface)
- A relatively impermeable
physical barrier
- Has glands secreting
lysozymes (breaks bacterial cell wall), toxic lipids (sebum), and hydrogen irons (H+)
Mucosal Defense - The Environment
• The mucosal epithelium
- Including GI, nasopharynx, upper airway,
urinary and reproductive track
- Not keratinized
- Moist and rich in nutrients
Mucosal Defense - Mechanical
• Local bacterial proliferation is controlled by mechanical cleaning, soluble bactericidal factors and lack of available free iron.
- GI track:
Peristaltic mobility, mucus secretion, stomach acid, bile as a detergent
- Lower respiratory track
A sterile environment
Mucus movement of cilia lining to remove aspirated bacteria
- Urinary track
A sterile environment
Urination serves to flush out bacteria
- Cigarette smoking, viral or bacterial infections and reduced mucociliary clearance in the elderly comprise immune defense and promote opportunistic infections
Mucosal Defense - Bactericidal
• Bactericidal Agents in Mucosal Fluids:
(Saliva, tears, nasal, gastric, cervical and
bronchial mucus)
- Lactoferrin: binds free iron
- Defensin: forms pores in bacterial membrane to allow efflux of irons and nutrients
- Lysozyme: breaks bacterial peptidoglycan
- IgA: interferes with bacterial adhesion,
inactivates toxins, promotes bacterial aggregation for removal by mucus
Lactoferrin
Binds free iron, inhibits bacterial growth
Defensin
Forms pores in bacterial membrane
to allow efflux of irons and nutrients
Why is important to limit the amount of free iron in the blood?
Iron is a vital nutrient for bacterial growth and is often the factor that limits growth in vivo. Iron is essential for many physiological processes in bacteria and fungi, including DNA replication, transcription, metabolism, and energy generation. Iron is also a co-factor for various proteins and can influence other cell components. For example, in Escherichia coli, iron is needed for the functioning of ribo-nucleotide diphosphate reductase subunit B2, which is responsible for synthesizing deoxy-ribotides for DNA synthesis.
Lysozyme
Breaks bacterial peptidoglycan (so probably contributes to why gram-negative bacteria are more difficult to deal with)
IgA
Interferes with bacterial adhesion, inactivates toxins, promotes bacterial aggregation for removal by mucus
How extracellular bacteria work around skin and mucosal defense mechanisms?
- Physical damage to the skin allows bacterial entry into tissue
- Mucosal bacteria can also actively invade deeper tissues through multiple mechanism including producing enzymes to destroy host tissues.
- H. pylori produces urease to generate ammonia to neutralize stomach acid.
- Inflammation caused by initial bacterial infection could lead to tissue damage, allowing additional bacterial entry.
How does H. pylori survive in the stomach?
Produces ammonia from urea to neutralize the acid + they bind specifically to gastric-type epithelium to prevent being shed
Once entering the body, bacteria
encounter:
• Innate Immunity: Rapid Response for Removal
- Blood Stream: Complement System
- Blood Stream: Neutrophils
- Tissue
▪ phagocytosis of bacteria by macrophages
▪ subsequent activation of both cell types release
inflammatory factors to induce neutrophil infiltration
▪ Neutrophils phagocytose bacteria
• Adaptive Immunity: Long-term Control
- Tissues: Dendritic Cells, Macrophages
- B cells
- End Result: antibody production
How extracellular bacteria work around immune defense mechanisms?
• Increase chance of colonization and growth
- Use surface molecules (e.g., adhesins) as ligands to host’s receptors to establish strong adhesion to the surfaces of host
epithelial cells
- Compete with host cells for iron in mucosa and blood as a vitalnutrient:
- N. meningitidis use a complex surface transport system to steal
iron from host’s transferrin
- E. coli secrete high affinity iron chelators (siderophores) to steal
soluble iron in the local environment before taking it up and releasing it into their cytoplasm.
Adhesions
Protein complexes that bind to protein receptors on the host cell surface
Bacterial capsule: Reduce immune cell recognition
- Mimicry: make bacterial capsule components more like eukaryotic
cell surface (polysaccharides)
- Mask: cover up surface antigenic epitope
- Inaccessibility: Antibodies and complements bound to antigenic structures deep beneath surface are less effective for phagocytosis
- Phase Variation: Dynamically express capsular polysaccharides (CPS) in response in stages of invasion:
* high (on) when needed for evading host immune response in initial invasion,
* low or no (off) when needing to adhere to or enter host cell,
* high (on) again after gaining access in deeper tissue with high abundance of complement and phagocytes.
**Means to reduce tagging and phagocytosis:**
• Proteins in the outer layer that inhibit complement deposition
- PspA/C (pneumococcal surface protein A/C)
- C3 binding protein (S. pneumoniae)
• Proteins in the outer layer that prevent antibody binding:
- protein A of Staphylococcus aureus binds to Fc region (the constant bottom region) of Ig and Fc prevent opsonization and phagocytosis. Then the bacteria is able to release itself.
• Bacterial Ig A proteases (e.g., Neisseria G/M) removes Fc fragment
of bound antibody (stops neutrophil phagocytosis & prevent immune detection by covering up its antigen---very clever!!!)
Means to reduce chance of being killed:
• Use pneumolysin (S. pneumoniae) to deplete complement
proteins
• Use C5a peptidase (S. pyogenes, group B streptococci) to
inactivate C5a (chemoattractant) and reduce neutrophil
infiltration
• Produces antioxidants (S. aureus) to inactivate neutrophil free radicals.
• Use catalase (E. Coli) to convert neutrophil H2O2 to water.
Intracellular Bacteria: Overview
- Invade host cells
- Survive and replicate inside host cells
- Spread to other cells/tissues within the host
- Cause systemic infection
A limited number of “strategically positioned” immune and non-immune cells can be used a target host cells.
- “First encounter” barrier cells: epithelial cells
(mucosa, GI and respiratory)
- “First encounter” immune cells: macrophages
(monocytes), neutrophils
- “Barrier/lining” cells: endothelial cells
- “Others”: hepatocytes, erythrocytes, Schwann cells
(PNS glia)
Immune Cells as Target Host Cells
- Immune cells (macrophages, neutrophils) are designed to recognize extracellular bacterial
PAMPs via PRR as well as Ig or complement- tagged bacteria via Fc Receptors or Complement Receptors.
- Recognition by immune cells leads to phagocytosis and degradation of the ingested bacteria.
- Intracellular bacteria that are able to remain and
replicate inside a host immune cells usually stay
in vacuoles, avoiding being killed.
Endocytic (Exogenous) Pathway
The usual Process:
• Extracellular microbe
phagocytized by an
immune cell results in the
breakdown of the microbe
and its presentation by
MHC-II.
• The end result is antibody
production against the
microbial epitopes.
MHC
• Major Histocompatability complex, a set of proteins found on the plasma membranes of cells that help display antigen to T cells.
• MHC I is found on all cells and displays bits of proteins from within the cell; this allows T cells to monitor cell contents and if abnormal peptides are displayed on the surface, the cell is destroyed by killer T cells.
• MHC II is found only on macrophages and B cells. This class of MHC allows these cells (known as antigen presenting cells) to display bitts of "eaten" (phagocytosed or internalized) proteins on their surface, allowing the activation of helper Ts --> thus further activating immune response.
Evasion of the Endocytic Pathway
• Prevention of phagolysosome formation
- Mycobacterium tuberculosis can impair
lysosomal acidification, a process required for
proper fusion of endosome with lysosome.
• Prevention of free radical mediated killing in
neutrophils
- Anaplasma phagocytophylum can prevent the production and proper assembly of NADPH
oxidase cytosolic and membrane subunits so
free radicals can not be generated to enable
the killing of the ingested bacteria.
• Escape from phagosome and enter cytosol
- Listeria monocytogenes secretes, listeriolysin O (LLO), a protein that ruptures phagosome.
Advantage:
a) Able to rapidly replicate due to available ingredients in cytosol
b) Facilitates repeated infection of neighboring host cells
Disadvantage:
Bacterial proteins in the cytosol of the host cells can be processed and presented by MHC-I resulting in the recognition
and killing of the host cell by a CD8+ cytotoxic T cell.
Non-immune Cells as Target Host Cells
• Non immune cells can not actively recognize and phagocytose bacteria.
• Bacteria, on the other hand, enter non-immune cells by inducing their own
phagocytosis.
• Non-immune cells are also poorly equipped to kill intracellular bacteria.
• Hence, invasion of non-immune cells enables bacteria to proliferate and invade more cells.
**Example: Orally introduced Salmonella enterica “crossing” GI epithelial cell membrane to eventually “enter” the epithelial cell.**
- A bacterium encounters GI epithelial cell surface
- It assembles a multiprotein needle complex (type 3 secretion system, T3SS), crossing bacterial inner and outer membrane and epithelial plasma membrane, to form a channel between bacterial cytosol and the epithelial cytosol
- It then injects “effector proteins” into the epithelial cells to induce cytoskeleton rearrangement that results in the engulfment of the bacterium.
- It can remain in the original vacuole formed by host cell membrane to replicate and infect neighboring cells.
- Similar mechanisms are believed to be used by other bacteriato invade non-immune cells.
Immune Response
against Intracellular Bacteria
• Immune responses to intracellular
bacteria are not as effective as that to extracellular bacteria.
• Primarily mediated by cellular immunity.
Innate Immunity: Neutrophils and
Macrophage
• Effective in infections that cause the death of host
cells.
Examples:
- Infection of epithelial cells by L. monocytogenes
causes the apoptosis of the infected epithelial cells
and the release of chemoattractant to recruit
neutrophil infiltration and the phagocytosis of the
released bacteria.
- Released bacteria will also cause macrophage
activation and phagocytosis and the release of
cytotoxic factors. If the phagocytosed bacteria can
not be killed, granuloma is formed to contain the
bacteria.
CD8+ T Cells and Intracellular Bacteria
• When intracellular bacteria replicate inside the host cell, some of its components will be processed as antigens and presented by MHC-I host P / G cells which will be killed by CD8+ T cells.
• Are also known a cytotoxic T cells
CD4+ T Cells and Granuloma
• Formation of granuloma serves to contain intracellular bacteria if
they can not be completely eliminated.
- Example: L. monocytogenes, M. tuberculosis
- Structure: a core of pathogen-containing macrophages and
scattered CD4+ T cells, surrounded by a layer of CD8+ T cells; in
most cases, cells in the core eventually die of apoptosis and the outer layer T cells become calcified and fibrotic.
Process:
• Macrophages fail to kill phagocytosed bacteria instead release IL-12.
• IL-12 activates T-helper cells to release IFN-γ that hyperactivate microphages to release more ROS and RNS to enhance killing
• Hyperactivated macrophages fuse together to form the core
• Remanent CD4+ and CD8+ T cells form the shell.
**Granuloma Formation Process**
• Macrophages fail to kill phagocytosed bacteria instead release IL-12.
• IL-12 activates T-helper cells to release IFN-γ that hyperactivate microphages to release more ROS and RNS to enhance killing
• Hyperactivated macrophages fuse together to form the core
• Remanent CD4+ and CD8+ T cells form the shell.
Antibody and Intracellular Bacteria
Limited participation
• Blocking bacteria and host receptor for
entry into host cells
• Opsonization of extracellular bacteria to
prevent entry into host cells
• Antibodies taken into the phagosome, together with the bacteria can act in situ
Example: Anti-LLO (listeriolysin O) antibody
protects against L. monocytogenes infection
Do gram negative bacteria have an outer membrane?
Yes, it has both an inner and outer membrane. It also has LPS on that outer membrane.
LPS-induced inflammatory response
• Lysed LPS binds to TLR4 leading to a cascade of events that lead to a. cytokine storm + cytotoxic peroxynitrite + TNF-alpha + interleukins + interferons, the cycle will continue as more immune cells are recruited, leading to sepsis
TLR4-related signaling pathway
• LPS: lipopolysaccharide
• CD14:
• MD-2: Myeloid Differentiation
factor 2
• Adaptor protein: MyD88
• Kinases: MAPK (mitogen-
activated protein kinases).
• AP-1, NF-kB: gene transcription
factors
Between innate and adaptive immunity, which plays a bigger role in defense
against extracellular bacteria?
Innate immunity
Between innate and adaptive immunity, which plays a bigger role in defense
against intracellular bacteria? Which cell type-mediated immunity is most
important?
Adaptive immunity, innate immunity is effective for infections that cause the death of host cells.
T-cell mediated adaptive immune response is most important.
Can you cite examples of host and bacterial proteins used to keep or steal free iron?
Too Keep by Host
1. Transferrin binds to iron
2. Increase iron storage
3. Lactoferrin binds to free iron
Too Steal by Bacteria
1. N. meningitidis use a complex surface transport system to steal iron from host’s transferrin
2. E.coli secrete high affinity iron chelators (siderophores) to steal
soluble iron
Can you cite examples of host and bacterial proteins used to facilitate
phagocytosis of bacteria or disruption of it?
Facilitate Phagocytosis of Bacteria by Host
1. Opsonization of foreign bodies by antibodies or complement proteins or Ig
2. Recognization of PAMPS by PRRs macrophages and neutrophils
3.
Disruption by Bacteria
1. Mycobacterium tuberculosis can impair
lysosomal acidification
2. Prevent recognition through mimicry, mask or inaccessibility or phase variation
3. Proteins in the outer layer that inhibit complement deposition
- PspA/C (pneumococcal surface protein A/C)
- C3 binding protein (S. pneumoniae)
4. Protein A of S. Aureus binds to Fc to prevent opsonization and phagocytosis
5. Ig A proteases (Neisseria G/M) removes Fc fragment of bound antibody
6. Anaplasma phagocytophylum can prevent
the production and proper assembly of NADPH
oxidase cytosolic
7. Listeria monocytogenes secretes, listeriolysin O (LLO), a
protein that ruptures phagosome.
Intracellular Bacteria Pathway
1. Invade host cell
2. Survive and replicate inside host cells
3. Adapt a way to transfer to other cells
4. Infect new cell
5. Repeat process to systemic infection
Bacterial Evasion: Taking charge ofhost proteins e.g. L. Monocytogenes
1. Invade Macrophages via vacuoles
2. Break out of vacuoles into the cytoplasm
3. ActA protein recruits host Actin filaments to move bacteria to cell membrane and push a protrusion into neighboring cells
4. Neighboring cells take up protrusions as vacuoles
5. Repeat process to systemic infection
Bacterial Evasion: Taking over ormimicking cell organelles e.g. example Legionella pneumophila
1. Invade host cell via Vacuoles
2. L. pneumophila dodge the cell’s immune defenses by interacting with Golgi bodies and ER. Taking some of their proteins and changing their normal vesicular traffic.
3. Newly formed membranes become studded with ribosomes
- To potentially make certain host proteins or could be a result of the membrane’s ER-like identity
4. L. pneumophila replicate inside compartment before bursting out of the cell
5. Repeat process to systemic infection
Bacterial Evasion: Change host cell gene expression e.g. M. Leprae
• M. leprae reprogram cell gene expression reverting them to stem-cell-like state.
• The new stem cell phenotype can differentiate into other cell types like muscle cells. Leading to infection of neighboring tissues.
• Reprogrammed cells also attract macrophages which phagocytose the stem cell-like cell and take up the infection and spread it.
What is LPS? How does LPS induce the production of various proinflammatory
and cytotoxic factors in an immune cell?
LPS is a lipopolysaccharide endotoxin found on the outer membrane of gram negative cells. It is a PAMP recognize by immune cells.
Where is all the toxicity contained in LPS?
Lipid A; O antigen is immunogenic and highly variable
Enterobacterales Overview
Enterobacterales Overview
Enterobacterales
• Family
– Domain: Bacteria
– Phylum: Proteobacteria
– Class: Gammaproteobacteria
– Order: Enterobacterales
– Family: Enterobacteriaceae
• 63 genera with 25+ species
• Natural habitat (normal microbiota)
– Lower gastrointestinal tract (human and animals)
– Ubiquitous (water and soil)
• Gram-negative facultative anaerobe, bacilli, lactase +, oxidase -
• Has a flagella
• Mucoid
– Found on the blood agar plate
– Mix with KOH solution à viscous form
• Voges-Proskauer
– Biochemical test
– Glucose fermentation producing products – acetoin/butylene glycol
• Hydrogen sulfide
– Biochemical test: to detect colorless gas H2S
Lactose Test
• Checks to see if a bacteria can ferment lactose
• Ferment sugar (glucose or lactose) à create acidic byproducts +/– gas à
pH indicator
• Can use the MacConkey agar
Oxidase Test
Identifies bacteria that have cytochrome oxidase
– Possess cytochrome oxidase or
indophenol oxidase
– Catalyze the transport of electrons from donors to electron acceptors
– Reagent: artificial electron acceptor
Surface Antigenic Feature: Cell Envelope
• Inner Membrane (cytoplasmic membrane)
– Impermeable to polar molecules
• Periplasmic Space
– Between the inner and outer membrane
– Peptidoglycan
• Outer Membrane
– Phospholipids inner leaflet
– Lipopolysaccharide in the outer leaflet which serve as antigens (PAMP)
Surface Antigenic Feature: Lipopolysaccharides (LPS)
• Lipid A (endotoxin)
- Recognized by host pattern
recognition receptor
• Core phosphyorylated
oligosaccharide
• Repeating oligosaccharide
side chains (O antigen)
• Extremely potent virulence factor
Immunoglobulins
Antibodies such as IgA, IgE, IgG, IgM, and IgD; secreted by plasma cells (mature B cells) in response to the presence of an antigen.
Surface Antigenic Feature: Capsule
• Envelope of surface polysaccharide
• Repeating trisaccharide
– Bonded to LPS and/or phosphoglyceride
• Ability to mask the O antigen from antibodies
Virulence/Virulence Factors
• Lipopolysaccharide and capsule
• Adhesins
• Secretion systems and Toxins
• Iron acquisition
• Plasmids
Adhesins
• Bind selectively to receptors on host
– Overcome electrostatic repulsion
• Fimbriae
– Rigid rod (pili) of FimA protein
– Binds to mannose residues on glycoprotein/glycolipids on host
• Outer membrane proteins: serve as adhesin
• Surface carbohydrates – adhesive properties
Toxins
• Released into the environment or
directed to the host cells
• SPATE: serine protease autotransporters
• Capable of inducing lysis of host cells
– Type I secretion system: hemolysins
– Type II secretion system: variety of enzymes e.g. chitinase
– Type III secretion system: exports and injects into cell
Plasmid
• Extrachromosomal autonomously replicating DNA
• Genes may play major roles in pathogenesis
– Type III secretion system: invade cells
– Pilus
– Type II: protease/hemolysins
• Transfer between different genera (conjugation)
• Resistance genes: antibiotic resistance
Antibiotic Resistance
• Produce beta-lactamase
– Intrinsic resistance
• Penicillinase – enzyme that degrades
– Break down penicillin
– Break down ampicillin
• AmpC producers – stronger enzyme
– Break down most cephalosporins (e.g. cefazolin, cefuroxime, and ceftriaxone)
– Extrinsic resistance (plasmid-mediated)
• Extended-spectrum beta-lactamase (ESBL)
• Mutational alterations of targeted sites
– Fluoroquinolones (ciprofloxacin)
– Aminoglycosides (gentamicin)
Escherichia
Escherichia
Discovery of Escherichia
• 1885 – Theodore Escherich
– Fecal microbiota in neonates
• One of most common genera
– Most commonly encountered pathogen
• This very distinguishable
– Motile (flagella)
– Produce indole from tryptophan (indole +)
• Poorly adapted to cause disease in healthy
- Opportunistic
• Includes E. Coli
Hemolysis
Destruction of red blood cells
E. Coli
• Gram stain: negative rod
• Motile
• Facultative anaerobes
• Lactose fermenter: positive
• Oxidase test: negative
• Hemolysis on sheep’s blood agar: positive
• Voges-Proskauer reaction test: negative
• Commonly found – Normal Microbiota (Normal Flora)
– Gastrointestinal
Pathogenesis: E. coli Diarrhea
• Very common worldwide
• Virulence Classification
- Enteropathogenic E. coli
- Enterotoxigenic E. coli
- Shiga toxin-producing E. coli
- Enteroinvasive E. coli
- Enteroaggregative E. coli
Enteropathogenic E. coli (EPEC)
• Developing countries (infants)
• Watery diarrhea with vomiting and fever
• Pilus: adherence factor (EAF)
– Adherence to
mucosal cells
of small intestine
• Inject effector
proteins
• Form actin
pedestal to bind/anchor to mucosal cells
Enterotoxigenic E. coli (ETEC)
• Traveler's Diarrhea and children < 5 yrs
• Adherence to
epithelial cells of
small intestine
• Enterotoxins
- Heat labile (LT)
• Mostly found
- Heat stable (STa)
• Some
• Plasmid mediated
Shiga toxin-producing E. coli (STEC)
Most often associated w/ foodborne outbreaks, HUS-related
• Diarrhea → Death
– Mild (non-bloody) to hemorrhagic colitis
• Virulence: cytotoxin (Shiga-like toxin-1 and toxin-2)
– Block protein synthesis and induce host cell apoptosis
– Released in stressful conditions e.g. exposure to antibiotics
• O157:H7 most common (serotype of E. coli)
– Responsible for large outbreaks
• Normal microbiota: ruminant (cattle)
– Under cooked meat and unpasteurized food
How do you treat STEC?
Supportive care
O157:H7 Outbreak in 1992
• Infected 732 people in the US
- 6 western states
- Strain was detected in stool 38 days after illness onset
- 23% were hospitalized → 4 children died
• Contaminated beef patties
- 11 lots of patties and 5 slaughter plants in the US and 1 in Canada
• Undercooked burgers and cooked burgers
- Since toxins are heat stable
Penicillinase
Enzyme produced by bacteria that deactivates penicillin
Antibiotic Resistance of E. Coli
• Intrinsic resistance: penicillinase
– Resistant to penicillin
– Resistant to ampicillin
• Some may have more resistance
– Depends on acquisition of plasmids
Infectious Diseases Attributable to E. coli
• Diarrhea
– Traveler’s diarrhea
– Food poisoning to hemorrhagic colitis
• Urinary tract infection
– Cystitis
– Pyelonephritis
– Bloodstream infection
• Intra-abdominal infections
Treatment options for E. Coli
• Ampicillin/sulbactam* - Beta - lactamase
• Cefazolin* - 2nd gen ceph
• Cefuroxime - 3rd gen ceph
• Ceftriaxone
• Ciprofloxacin*
Klebsiella
Klebsiella
Discovery of Klebsiella
• 1882: Carl Friedländers
– Lobar pneumonia caused by Klebsiella
– Sweats, fever, pleuritic pain with bloody sputum
– Bulging interlobar fissures on x-ray
• 1885: V. Trevisan: honored Theodor Albrecht Edwin Klebs
• Common in the community and in the hospital setting for infections
Voges-Proskauer Test
Designed for organisms that are able to ferment glucose, but quickly convert their acid products to acetoin and 2,3-butanediol; adding VP reagents to the medium oxidizes the acetoin to diacetyl, which in turn reacts with guanidine nuclei from peptone to produce a red color
Klebsiella: pneumoniae, oxytoca, aerogenes
• Gram stain: negative
• Facultative anaerobes
• Lactose fermenter: positive
• Oxidase test: negative
• Hemolysis on sheep’s blood agar: negative
• Voges-Proskauer reaction test: positive
• Exhibit mucoid growth and non-motile (except aerogenes: motile)
• Commonly found – Normal Microbiota (Normal Flora)
– Gastrointestinal
Klebsiella: Virulence Factor
• Polysaccharide capsule
- 70 antigenic varieties
- Responsible for the mucoid phenotype
- Inhibit phagocytosis
• Fimbrial types - pili
- Adherence to host cells
• LPS
• Plasmids
Klebsiella: Antibiotic Resistance
• Chromosomal gene encoding penicillinase
– Resistant to ampicillin and amoxicillin
• Nosocomial (originating in hospital) isolates may be resistant to other antibiotics
– Plasmid mediated
• Extended spectrum beta-lactamase production (ESBL)
– Resistant to all cephalosporin
• Klebsiella producing carbapenemase (KPC)
– Resistant to cephalosporins and carbapenems
• Resistant to fluoroquinolones (ciprofloxacin)
• Resistant to aminoglycosides (gentamicin)
Infectious Diseases Attributable to Klebsiella sp.
• Urinary tract infections
• Respiratory tract infections
• Intra-abdominal infections
– Liver abscess
– Biliary tract infections
– Peritonitis
• Wound infections
ESBL
Resistant to all cephalosporins : O
Klebsiella: Treatment
• Cefazolin*
• Cefuroxime*
• Ceftriaxone*
• Cefepime*
• Piperacillin/tazobactam*
• Meropenem
- These cephalosporins will not be effective if the bacteria is ESBL producing, so do not use if there is a risk that they might be ESBL
Enterobacter
Citrobacter
Serratia
Enterobacter
Citrobacter
Serratia
Discovery of Enterobacter
• Widely identified as a pathogen in 1970
– Nationwide outbreak of septicemia
– 378 patients @ 25 hospitals
– Contaminated IV solutions from Abbott Laboratories
• Hospital-acquired infection
– Received antibiotics previously
– Admitted in the intensive care units
Enterobacter species: cloacae
• Gram stain: negative
• Facultative anaerobes
• Lactose fermenter: positive
• Oxidase test: negative
• Hemolysis on sheep’s blood agar: negative
• Voges-Proskauer reaction test: positive
• Motile and exhibit mucoid growth
• Commonly found – Normal Microbiota (Normal Flora)
– Gastrointestinal
• All the same characteristics of Klebsiella except it is motile (although aerogenes is motile)
Hydrogen Sulfide Test
Tests bacteria with abilty to turn H2S from amino acids or other sulfur-containing compounds. Gives off a black color
Discovery of Citrobacter
• 1932: Werkman and Gillen
– Urinary pathogen in a hospitalized patient
• Named after their ability to use citrate as their sole carbon source
• Produce H2S (positive test)
– Not many Enterobacterales produce this
Citrobacter species: Koseri and fruendii
• Gram stain: negative
• Facultative anaerobes'
• Lactose fermenter: positive
• Oxidase test: negative
• Voges-Proskauer reaction test: negative
• Motile
• Sulfide Test: positive
• Commonly found - Normal Microbiota (Normal Flora)
- Soil and water
- Gastrointestinal tract in animals and humans
• Very similar to E. Coli, except no mention of hemolysis and it has a positive sulfide test
Discovery of Serratia
• Wide spread in the environment
– Less common in the human fecal flora
– Saprophytic bacteria
• Produce exotoxin: Dnase
• Produce a red pigment- prodigosin
– Polenta cultivated with red discoloration
• Named after Serafino Serrati
– Actually invented the steamboat engine
– Species marcescens Latin term: to decay
Serretia Species: marcesens
• Gram stain: negative
• Facultative anaerobes
• Lactose fermenter: positive
• Oxidase test: negative
• Hemolysis on sheep’s blood agar: negative
• Voges-Proskauer reaction test: positive
• Motile
• Commonly found – Normal Microbiota (Normal Flora)
– Environment
• All the same characteristics of Enterbactor cloacae OR of Klebsiella except it is motile (although aerogenes is motile)
Virulence Factors: Serratia sp
• Chromosomal inducible ampC genes encoding beta-lactamases to degrade certain antibiotics
– Resistance to
• Ampicillin
• Cefazolin
• Cefuroxime
• Ceftriaxone
• Carry plasmids encoding resistance to multiple antibiotics
• Fimbriae
– Allows adherence to uroepithelial cells
– Cytotoxic to tissue cells
• Able to survive in harsh conditions
– Thrive with disinfectants
– Spread through hospital personnel hands
• ampC gene produce higher levels of beta-lactamases during
therapy
ampC
Gene codes for beta lactamase
-regulated by AmpR
– Resistance to
• Ampicillin
• Cefazolin
• Cefuroxime
• Ceftriaxone
**Infectious Diseases Attributable to Enterobacter sp.**
• Respiratory tract infection
– Pneumonia
• Urinary tract infections
– Indwelling catheter
• Intra-abdominal infections
• Wound or burn related skin infections
Infectious Diseases Attributable to Citrobacter sp.
• Urinary tract infections
– Indwelling catheter
• Respiratory tract infection
– Pneumonia vs. colonization
• Intra-abdominal infections
• Wound infection
• Osteomyelitis